Biotech Showcase Digital 2021

Featured Presentations

IN CONVERSATION WITH THE COVID-19 LEADERS: The UK Perspective

Registered Attendees View Here

On 2020年12月8日, the UK became the first Western country to deliver a broadly tested and independently reviewed vaccine to the general public. This session will discuss the path to reaching this momentous milestone – in short time – how the country is approaching the massive task of rolling out the vaccine to its entire population, and lessons that have been learned along the way.

Moderator:

• Jaime E. Hernandez, MD, Executive Medical Director, Infectious Disease and Vaccines, Syneos Health

Panelists:

• Steve Bates, CEO, BioIndustry Association
• Kate Bingham, Former Chair, U.K. Vaccine Taskforce and Managing Partner, SV Health Managers LLP

IN CONVERSATION WITH THE COVID-19 LEADERS: A Sense of Urgency with Vaccines and Mobilizing Collaboration

Registered Attendees View Here

Senior leaders of the companies developing vaccines for COVID-19 will share their insights and firsthand experiences of rising to the occasion to address this urgent need.

Moderator:

• Paul Colvin, President, Clinical Solutions, Syneos Health

Panel: To Spend or Not to Spend: Investing for Commercial Success as an Emerging Company

Registered Attendees View Here

Based on two years of survey data and market analysis, this interactive session will drill down on perception versus reality around level of investment needed – and where to spend – for a successful product launch. Download our Report Here

Moderators:

• Naveen Murthy, Senior Managing Director, Consulting, Syneos Health
• Sachin Purwar, Director, Consulting, Syneos Health
• Michael Sarshad, Director, Consulting, Syneos Health

Panel: Investing in Diversity

View for Free Here

It has become clear that diversity in all forms – ethnic, racial, gender, age – leads organizations to greater success. We know that different perspectives and experiences create more opportunities. Join us to discuss what our industry is doing to invest in diversity as a powerful resource.

Panelist:

• Lucy Abreu, Senior VP, Diversity, Equity and Inclusion Strategist and Employee Engagement Lead, Syneos Health Communications

Panel: The Digitization of Clinical Trials

View for Free Here

COVID-19 accelerated the adoption of decentralized clinical trials (DCT) and use of digital health/AI tools to support clinical trials. This panel will explore the new technologies increasing access to clinical trials and partnership and investment trends. Panelists will examine the long term landscape discussing how deliberate study planning and protocol optimizing DCTs effectively will differ than the ‘ad hoc’ use of services during COVID and how DCTs are creating diversity in clinical trials.

Moderator:

• Maria Fotiu, EVP, Decentralized Solutions, Syneos Health

Fierce JPM Week Panel: Rerouting: How Real-Time Patient Data Will Drive the Future of Healthcare

View for Free Here

There can be no mention in today’s clinical trial world without considering decentralised capabilities. The continued digitization of trials combined with the COVID-19 pandemic have thrust trials into new and unexplored pathways. Now, with several companies heralding the promise of real-time data, the industry may be about to take a sharp right turn. Join our speakers as they discuss the possibilities of continuous patient monitoring and digital therapeutics while outlining several new pathways that real-time patient data promises to deliver.

Panelist:

• Maria Fotiu, EVP, Decentralized Solutions, Syneos Health